Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,309 | -8,578 | -2,823 | -1,401 | -3,485 |
| Depreciation Amortization | 751 | 1,176 | 736 | 359 | 1,443 |
| Accounts receivable | -1,683 | -1,662 | -684 | -1,112 | 1,856 |
| Other Working Capital | -2,514 | -3,268 | 857 | -1,373 | 58 |
| Other Operating Activity | 4,187 | 763 | -1,876 | 1,147 | -2,454 |
| Operating Cash Flow | $-14,568 | $-11,569 | $-3,790 | $-2,380 | $-2,582 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,161 | -852 | -721 | -564 | -722 |
| Net Acquisitions | 26,037 | 26,037 | 26,037 | N/A | N/A |
| Other Investing Activity | 207 | 214 | 0 | 0 | -8 |
| Investing Cash Flow | $25,083 | $25,399 | $25,316 | $-564 | $-730 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 13 |
| Other Financing Activity | -588 | -386 | -198 | -94 | -370 |
| Financing Cash Flow | $-588 | $-386 | $-198 | $-94 | $-357 |
| Exchange Rate Effect | -212 | -124 | -202 | -134 | 157 |
| Beginning Cash Position | 6,678 | 6,678 | 6,678 | 6,678 | 10,190 |
| End Cash Position | 16,393 | 19,998 | 27,804 | 3,506 | 6,678 |
| Net Cash Flow | $9,715 | $13,320 | $21,126 | $-3,172 | $-3,512 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,568 | -11,569 | -3,790 | -2,380 | -2,582 |
| Capital Expenditure | -1,161 | -852 | -721 | -564 | -722 |
| Free Cash Flow | -15,729 | -12,421 | -4,511 | -2,944 | -3,304 |